C07D

Heterocyclic Compounds (Drug Molecules)

USPTO Patent Applications

← All categories

83 items

Application

Light Emitting Element And Polycyclic Compound For Light Emitting Element

US20260082810A1 · Mar 19, 2026
H10K C07D
Application

Heterocyclic Compound, Organic Light Emitting Device Comprising The Same And Composition For Organic Material Layer

US20260082809A1 · Mar 19, 2026
H10K C07B
Application

Compound For Organic Optoelectronic Device, Composition For Organic Optoelectronic Device, Organic Optoelectronic Device, And Display Device

US20260082808A1 · Mar 19, 2026
H10K C07B
Application

Compound And Organic Light Emitting Device Comprising Same

US20260082806A1 · Mar 19, 2026
H10K C07D
Application

Organic Electroluminescent Materials And Devices

US20260082803A1 · UNIVERSAL DISPLAY CORPORATION · Mar 19, 2026
H10K C07D
Application

Fluorescent Sensors For Marijuana Breath Test

US20260079109A1 · Mar 19, 2026
G01N C07D
Application

Compound, Extracellular Vesicle Staining Agent, And Fluorescent Staining Method For Extracellular Vesicles

US20260079084A1 · Mar 19, 2026
G01N C07D
Application

Radiation Sensitive Composition, Method For Forming Pattern And Onium Salt Compound

US20260079396A1 · JSR CORPORATION · Mar 19, 2026
G03F C07C
Application

Resist Composition, Resist Pattern Forming Method, Compound And Acid Diffusion Control Agent

US20260079395A1 · Mar 19, 2026
G03F C07C
Application

Resist Composition, Method For Forming Resist Pattern, Compound And Acid Diffusion Control Agent

US20260079394A1 · Mar 19, 2026
G03F C07C
Application

Composite Catalyst With Molybdenum Mxene For Electrochemical Hydrogenation Of 2 Methylfuran

US20260078506A1 · Mar 19, 2026
C25B B01J
Application

Substituted N Propylamine Fused Heterocyclic Mescaline Derivatives

US20260078102A1 · Mar 19, 2026
C07D C07D
Application

Recovery Of Maleic Anhydride

US20260078101A1 · Mar 19, 2026
C07D
Application

Process For Reducing The Overchloriding Of High Selectivity Ethylene Oxide Catalysts During Restarts

US20260078100A1 · Mar 19, 2026
C07D
Application

Compound, Preparation Method Thereof, And Lipid Nanoparticle And Pharmaceutical Composition

US20260078099A1 · SUZHOU HEALIRNA BIOTECHNOLOGY CO., LTD. · Mar 19, 2026
C07D A61K
Application

Process Of Making Derivatives Of Substituted Morpholines

US20260078098A1 · Supernus Pharmaceuticals, Inc. · Mar 19, 2026
C07D B01J
Application

Piperazine Compounds

US20260078097A1 · Mar 19, 2026
C07D A61K
Application

Solid State Forms Of (S) 2 (((S) 6,8 Difluoro 1,2,3,4 Tetrahydronaphthalen 2 Yl)amino) N (1 (2 Methyl 1 (Neopentylamino)propan 2 Yl) 1 H Imidazol 4 Yl)pentanamide And Uses Thereof

US20260078096A1 · Mar 19, 2026
C07D A61K
Application

Neurotensin Receptor Ligands

US20260078095A1 · Mar 19, 2026
C07D A61K
Application

Anti Viral Compounds

US20260078094A1 · Mar 19, 2026
C07D A61K
Application

(4 R) 3 (4 Fluoro 2 Hydroxyphenyl) 4 Methyl 4,5 Dihydro 1 H Pyrazole 1 Carboximidamide Hydrochloride And Dermal Formulations Thereof

US20260078093A1 · IMMUNAHR AB · Mar 19, 2026
C07D A61K
Application

Sulfonyl Carboxamide Compound, Their Derivatives, And Uses Thereof

US20260078092A1 · Mar 19, 2026
C07D A61K
Application

Piperidinone Derivatives As Mdm2 Inhibitors For The Treatment Of Cancer

US20260078091A1 · Mar 19, 2026
C07D C07D
Application

N Substituted Indoles As 5 Hydroxytryptamine (5 Ht) Serotonin Receptor Agonists And Antagonists

US20260078090A1 · Mar 19, 2026
C07D C07D
Application

Bioactive Phytochemicals In Zizyphus And Guarana

US20260078089A1 · Phytoquest Limited · Mar 19, 2026
C07D A23L
Application

Ionizable Lipids For Nucleic Acid Delivery

US20260078085A1 · Mar 19, 2026
C07C A61K
Application

Improved Process For Preparing P Nitrobenzoic Acid 2 Ethylhexyl Ester

US20260078083A1 · Mar 19, 2026
C07C C07C
Application

Compounds And Compositions For Intracellular Delivery Of Therapeutic Agents

US20260078082A1 · Mar 19, 2026
C07C A61K
Application

Fragrance And Flavor Compositions Comprising Norbornane And Norbornene Derivatives

US20260078079A1 · Mar 19, 2026
C07C A23L
Application

Urease Inhibiting Composition And Use Of Same

US20260078068A1 · FERTINAGRO BIOTECH, S.L. · Mar 19, 2026
C05G C05C
Application

Compounds, Compositions, And Methods For Modulating Cftr

US20260078136A1 · Mar 19, 2026
C07F A61K
Application

Polycyclic Quinazolines For Inhibition Of Erbb2

US20260078135A1 · Mar 19, 2026
C07D A61K
Application

Macrocyclic Compounds As Ras Inhibitors

US20260078134A1 · BeOne Medicines I GmbH · Mar 19, 2026
C07D A61K
Application

Ras Inhibitors

US20260078133A1 · Mar 19, 2026
C07D A61K
Application

Solid Forms Of An Inhibitor Of Hif And Methods Of Using Same

US20260078132A1 · ONCOSPHERIX INC. · Mar 19, 2026
C07D
Application

Pyrrolo Pyridazine Inhibitors Of Jak2

US20260078131A1 · Mar 19, 2026
C07D C07B
Application

Nampt Modulators, Preparations, And Uses Thereof

US20260078130A1 · Mar 19, 2026
C07D A61K
Application

Jak Inhibitor And Preparation Method Therefor

US20260078129A1 · Mar 19, 2026
C07D
Application

Process For The Preparation Of Ruxolitinib And Novel Crystalline Form Thereof

US20260078128A1 · Mar 19, 2026
C07D
Application

Heterobicyclic Amides As Inhibitors Of Cd38

US20260078127A1 · Mar 19, 2026
C07D A61P
Application

Bicyclic Urea Kinase Inhibitors And Uses Thereof

US20260078126A1 · THE BROAD INSTITUTE, INC. · Mar 19, 2026
C07D A61K
Application

Tyk2 Inhibitors And Uses Thereof

US20260078125A1 · Mar 19, 2026
C07D C07D
Application

Methods Of Preparing Ergoline Analogs

US20260078124A1 · Mar 19, 2026
C07D C07D
Application

Pyrazolo[1,5 A]Pyridine Derivative, And Preparation Method And Use Thereof

US20260078123A1 · SHANGHAI DAIDAI INVESTMENT CONSULTING CO., LTD · Mar 19, 2026
C07D A61P
Application

Indazole Compounds As Pkmyt1 Kinase Inhibitors

US20260078122A1 · Hoffmann-La Roche Inc. · Mar 19, 2026
C07D A61K
Application

Inhibitors Of Enl/Af9 Yeats And Flt3

US20260078121A1 · Mar 19, 2026
C07D A61K
Application

Substituted Pyridopyrimidinones

US20260078120A1 · MIRATI THERAPEUTICS, INC. · Mar 19, 2026
C07D A61K
Application

Degrader Compounds And Uses Thereof

US20260078119A1 · Mar 19, 2026
C07D A61K
Application

Combined Product, Salt And Use Thereof

US20260078118A1 · Mar 19, 2026
C07D A61K
Application

Compounds And Methods Of Use

US20260078117A1 · Mar 19, 2026
C07D A61P
Application

Small Molecule Protein Synthesis Modulators

US20260078116A1 · Interdict Bio, Inc. · Mar 19, 2026
C07D A61K
Application

Aliphatic Acid Amide Derivative

US20260078115A1 · Sumitomo Pharma Co., Ltd. · Mar 19, 2026
C07D C07D
Application

Compound Used As Inhibitor Of Cdk4 Kinase And Use Thereof

US20260078114A1 · Mar 19, 2026
C07D A61K
Application

Heterocyclic Compounds As Immunomodulators

US20260078113A1 · Mar 19, 2026
C07D C07D
Application

New Crystal Form Of Isoxazoline Uracil Compound, Preparation Method, And Herbicide And Use

US20260078112A1 · Mar 19, 2026
C07D A01N
Application

Carbonic Anhydrase Enzyme Inhibitors And Methods Of Use Thereof

US20260078111A1 · RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY · Mar 19, 2026
C07D A61K
Application

Sesterterpenoid Compounds And Extract L01 Of Leucosceptrum Canum, And Use Thereof In Treatment Of Psoriasis

US20260078110A1 · Mar 19, 2026
C07D A61K
Application

Method For Preparing Sglt Inhibitor

US20260078109A1 · Mar 19, 2026
C07D C07D
Application

Solid Forms Of A Rock Inhibitor

US20260078108A1 · Mar 19, 2026
C07D A61K
Application

Csf 1 R Inhibitors And Methods Of Use Thereof

US20260078107A1 · Mar 19, 2026
C07D A61K
Application

Substituted Piperidino Compounds And Related Methods Of Treatment

US20260078106A1 · Mar 19, 2026
C07D A61P
Application

Novel Aminocarboxymuconate Semialdehyde Decarboxylase Inhibitors

US20260078105A1 · Mar 19, 2026
C07D A61K
Application

Organic Light Emitting Compound And Organic Electroluminescent Device Using The Same

US20260078104A1 · SOLUS ADVANCED MATERIALS CO., LTD. · Mar 19, 2026
C07D C07D
Application

Isoquinolones As Pi3 K Inhibitors

US20260078103A1 · OnKure, Inc. · Mar 19, 2026
C07D A61K
Application

Aromatic Eutectic Mixtures And Their Use As Solvents, Particularly In Liquid Liquid Separation

US20260077278A1 · COMMISSARIAT A L'ENERGIE ATOMIQUE ET AUX ENERGIES ALTERNATIVES · Mar 19, 2026
B01D C07C
Application

Squaramide Covalent Organic Frameworks

US20260077335A1 · Mar 19, 2026
B01J B01D
Application

Atp Independent Bioluminescent Reporter Variants To Improve In Vivo Imaging

US20260077068A1 · Mar 19, 2026
A61K C07D
Application

Compounds For The Degradation Of Egfr Kinase

US20260077051A1 · BeOne Medicines I GmbH · Mar 19, 2026
A61K A61K
Application

Agents For Cleaving Labels From Biomolecules In Vivo

US20260077076A1 · Tagworks Pharmaceuticals B.V. · Mar 19, 2026
A61K A61K
Application

Ionizable Lipids And Compositions Comprising Same

US20260076914A1 · Mar 19, 2026
A61K C07C
Application

Prodrugs Of Cannbidiol [Cbd] Type Phytocannabinoids And A Process For Preparation Thereof

US20260076982A1 · Mar 19, 2026
A61K A61K
Application

Tpk Agonist And Method For Using Same To Treat Neurodegenerative Diseases

US20260076975A1 · Mar 19, 2026
A61K A61K
Application

Antidiabetic Medications

US20260076972A1 · Mar 19, 2026
A61K A61K
Application

Aza Quinoline Compounds And Uses Thereof

US20260076968A1 · Mar 19, 2026
A61K A61K
Application

Heterocyclic Derivatives, Pharmaceutical Compositions And Their Use In The Treatment Or Amelioration Of Cancer

US20260076967A1 · Tolremo Therapeutics AG · Mar 19, 2026
A61K A61K
Application

Method Of Treating Sclc And Managing Thrombocytopenia

US20260076965A1 · Mar 19, 2026
A61K A61K
Application

Method Of Treating Sclc And Managing Hepatotoxicity

US20260076964A1 · Mar 19, 2026
A61K A61K
Application

Lanthionine Synthetase C Like 2 Based Therapeutics

US20260076962A1 · NImmune Biopharma, Inc. · Mar 19, 2026
A61K A61K
Application

Combination Product, Salt, And Use Thereof In Treating Neurodegenerative Diseases Or Disorders

US20260076959A1 · Mar 19, 2026
A61K A61K
Application

Stable Monohydrate Of Df2755 A And Process For Its Preparation

US20260076949A1 · Mar 19, 2026
A61K C07D
Application

Aryl Imino Tryptophan Derivatives

US20260076942A1 · Renovel Innovations, Inc. · Mar 19, 2026
A61K A61P
Application

Indolinone Compounds And Uses Thereof

US20260076941A1 · Mar 19, 2026
A61K A61K
Application

Chiral Gamma Lactam Derivative Or Pharmaceutically Acceptable Salt Thereof, And Preparation Method Therefor

US20260076939A1 · Mar 19, 2026
A61K A61P